Search global stocks & ETFs...Ctrl K
Learn Mode
ACB.TO logo

ACB.TO - Aurora Cannabis Inc

7


CA$4.96

-CA$0.10 (-1.976%)
At close: 5/29/26, 8:29 PM
Stock Unlock LogoScore

2.32/5

General
Scores
Financials & KPIs
Dividends
Analyst
Insider
ACB.TO
Valuation Score
View as %

(TO stock price quotes are delayed, fully updated by EOD)
Stock Unlock Logo
Stock Unlock
CA$4.29CA$8.75JunJulOctDecJanApr

1D
1W
1M
YTD
1Y
3Y
5Y
Max

Stock Profile
  • Market Cap
    CA$286.95M
  • Industry
    Pharmaceuticals
  • EPS (TTM)
    -CA$1.57
  • P/E (TTM)
    0.00
  • Div & Yield
    --
  • FCF Payout Ratio
    --
  • P/S (TTM)
    0.77
  • P/B
    0.53
  • Diluted Shares
    56.70M
  • Ex-Dividend
    --
  • Next Earnings
    06-18
  • Forward P/E
    25.85
  • Payout Ratio
    --
  • P/FCF (TTM)
    0.00
  • FCF Yield
    --
  • Earnings Yield
    -30.93%
  • 52 Week Range
2.32
Bad
Aurora Cannabis Inc has grown revenue at 16.54% over the past year, which is strong growth. However, it has a gross margin of 1.35%, which means it is not able to deliver its products/services very profitably.
Valuation Model
Key Score
4.00
Good
Management
2.00
Bad

Growth
4.00
Good

Profitability
3.00
Average
Fin. Health
1.00
Very Bad

Dividends
--
--

Analyst
1.00
Very Bad
Insider Transactions
Explore Insider Tab
Buy
Sell
Buy Back
20112014201520182019202020212022202320242025CA$0CA$6MCA$12MCA$18MCA$24M
Market News
Page 1 of 5











Page 1 of 5
Revenue
Earnings
Free Cash Flow
2022202320242025-CA$1.80B-CA$1.20B-CA$600MCA$0CA$600M
Price Targets
Go to Analyst Tab
These are one year price targets for: 2027-05-11
High:
CA$10.50
111.7%
Avg:
CA$7.77
56.7%
Low:
CA$5.05
1.8%
(% change is relative to the current stock price: CA$4.96)
Analyst Recommendations
Go to Analyst Tab
3.70
Good
10%
Strong Buy (1)
50%
Buy (5)
40%
Hold (4)
0%
Sell (0)
0%
Strong Sell (0)
About
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
  • IPO Date
    2007-09-26
  • Industry
    Pharmaceuticals
  • Total Employees
    1,101
  • Exchange
    Toronto Stock Exchange
  • Reporting Currency
    CAD
  • GICS
    Pharmaceuticals
  • GICS Sub
    Pharmaceuticals
  • GICS Sector
    Health Care
  • GICS Group
    Pharmaceuticals, Biotechnology & Life Sciences